London's FTSE 100 bogged down by GSK, Unilever; budget, Fed in focus

By Reuters News

- London's FTSE 100 slipped on Wednesday, with Unilever and GSK leading declines after their quarterly results, in a cautious market ahead of finance minister John Healey's first budget and the US Federal Reserve's interest rate decision.

The blue-chip FTSE 100 index .FTSE fell 0.3% to 10,652.43 points by 0954 GMT, while the midcap FTSE 250 .FTMC inched up 0.1%.

  • Healey planned to remove fixed gas standing charges from household energy bills from 2027, The Telegraph reported

  • He is expected to announce a cautious budget, trying to avoid more bond market pressure, with banks and gambling firms among those that could be taxed more

  • "It's really a waiting game... We're not expecting massive moves today and it's unlikely we'll see too many surprises," said Nick Saunders, CEO of investment platform Webull UK

  • Standard Chartered STAN.L gained 2.8% after the lender said it expects full-year operating income growth to exceed 7% — above its prior 5%-7% guidance

  • Unilever ULVR.L fell 2.2% after reporting softer results in its foods business, dragging the personal care, drug and grocery sector .FTNMX452010 down nearly 1.2%

  • GSK GSK.L bottomed the FTSE 100 with a 5.7% slump as its pipeline-build push and growth plans via a £1.9 billion ($2.52 billion) cost-savings drive failed to convince investors

  • The pharmaceutical and biotechnology sector .FTNMX201030 declined 1.7%

  • Brent crude futures rose 1.2% to $115.24 a barrel after an attack on a Saudi Arabian refinery renewed concerns over potential supply disruptions

  • The broader energy sector .FTNMX601010 was among the few gainers, rising 0.2%

  • "Financials, house builders, utilities and defence stocks are likely to be the most sensitive," Saunders said

  • Markets will closely watch the Fed's monetary policy meeting, where it is widely expected to hold interest rates steady

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.